- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
September 14, 2023
From InvestorPlace
Five things to know about the new COVID-19 vaccine
September 13, 2023
From MarketWatch
From Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
From Benzinga
New Pfizer and Moderna COVID shots approved by FDA
September 11, 2023
From MarketWatch
From Benzinga
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
From Benzinga
From Benzinga
Europe Approves Pfizer/BioNTech's Adapted COVID-19 Vaccine For Upcoming Autumn Vaccination Campaigns
September 01, 2023
From Benzinga
Why Novavax Stock Was So Healthy on Monday
August 28, 2023
From Motley Fool
5 Value Stocks To Watch In The Healthcare Sector
August 28, 2023
From Benzinga
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
August 27, 2023
From Motley Fool
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
From InvestorPlace
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
From Motley Fool
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
From Benzinga
Moderna, BioNTech And Other Big Stocks Moving Higher On Monday
August 21, 2023
From Benzinga
As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant
August 18, 2023
From MarketWatch
Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies
August 18, 2023
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
From InvestorPlace
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
August 11, 2023
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.